<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer-Verlag</PublisherName>
    <PublisherLocation>New York</PublisherLocation>
  </PublisherInfo>
  <Journal>
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>12248</JournalID>
      <JournalElectronicISSN>1550-7416</JournalElectronicISSN>
      <JournalTitle>The AAPS Journal</JournalTitle>
      <JournalAbbreviatedTitle>AAPS J</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="F" Type="Primary">Pharmacy</JournalSubject>
        <JournalSubject Code="F00008" Priority="1" Type="Secondary">Pharmacy</JournalSubject>
        <JournalSubject Code="B21007" Priority="2" Type="Secondary">Pharmacology/Toxicology</JournalSubject>
        <JournalSubject Code="C12002" Priority="3" Type="Secondary">Biotechnology</JournalSubject>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume>
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>7</VolumeIDStart>
        <VolumeIDEnd>7</VolumeIDEnd>
        <VolumeIssueCount>4</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular">
        <IssueInfo TocLevels="0">
          <IssueIDStart>4</IssueIDStart>
          <IssueIDEnd>4</IssueIDEnd>
          <IssueArticleCount>15</IssueArticleCount>
          <IssueHistory>
            <CoverDate>
              <Year>2005</Year>
              <Month>12</Month>
            </CoverDate>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
            <CopyrightYear>2006</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="Art3">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>74813</ArticleID>
            <ArticleDOI>10.1208/aapsj070478</ArticleDOI>
            <ArticleSequenceNumber>3</ArticleSequenceNumber>
            <ArticleTitle Language="En">The role of crystallography in drug design</ArticleTitle>
            <ArticleFirstPage>E813</ArticleFirstPage>
            <ArticleLastPage>E819</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2008</Year>
                <Month>1</Month>
                <Day>23</Day>
              </RegistrationDate>
              <Received>
                <Year>2005</Year>
                <Month>8</Month>
                <Day>24</Day>
              </Received>
              <Accepted>
                <Year>2005</Year>
                <Month>9</Month>
                <Day>22</Day>
              </Accepted>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
              <CopyrightYear>2005</CopyrightYear>
            </ArticleCopyright>
            <ArticleGrants Type="Regular">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="Restricted"/>
              <BodyHTMLGrant Grant="Restricted"/>
              <BibliographyGrant Grant="Restricted"/>
              <ESMGrant Grant="Restricted"/>
            </ArticleGrants>
            <ArticleContext>
              <JournalID>12248</JournalID>
              <VolumeIDStart>7</VolumeIDStart>
              <VolumeIDEnd>7</VolumeIDEnd>
              <IssueIDStart>4</IssueIDStart>
              <IssueIDEnd>4</IssueIDEnd>
            </ArticleContext>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff2">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Jeffrey</GivenName>
                  <GivenName>R.</GivenName>
                  <FamilyName>Deschamps</FamilyName>
                </AuthorName>
                <Contact>
                  <Phone>(202) 767-0656</Phone>
                  <Fax>(202) 767-6874</Fax>
                  <Email>deschamps@nrl.navy.mil</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1">
                <OrgDivision>Laboratory for the Structure of Matter</OrgDivision>
                <OrgName>Naval Research Laboratory</OrgName>
                <OrgAddress>
                  <Postcode>20375</Postcode>
                  <City>Washington, DC</City>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff2">
                <OrgDivision>Research Chemist</OrgDivision>
                <OrgName>Naval Research Laboratory</OrgName>
                <OrgAddress>
                  <Street>4555 Overlook Avenue</Street>
                  <Postbox>Code 6030</Postbox>
                  <Postcode>20375</Postcode>
                  <City>Washington, DC</City>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En">
              <Heading>Abstract</Heading>
              <Para>Structure and function are intimately related. Nowhere is this more important than the area of bioactive molecules. It has been shown that the enantioselectivity of an enzyme is directly related to its chirality. X-ray crystallography is the only method for determining the “absolute” configuration of a molecule and is the most comprehensive technique available to determine the structure of any molecule at atomic resolution. Results from crystallographic studies provide unambiguous, accurate, and reliable 3-dimensional structural parameters, which are prerequisites for rational drug design and structure-based functional studies.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Keywords</Heading>
              <Keyword>structure</Keyword>
              <Keyword>absolute configuration</Keyword>
              <Keyword>opioid</Keyword>
              <Keyword>pharmacophore</Keyword>
              <Keyword>X-ray diffraction</Keyword>
            </KeywordGroup>
            <ArticleNote Type="Misc">
              <SimplePara>Published: December 7, 2005</SimplePara>
            </ArticleNote>
          </ArticleHeader>
          <BodyRef FileRef="BodyRef/PDF/12248_2008_Article_74813.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibBook>
                  <BibEditorName>
                    <Initials>JF</Initials>
                    <FamilyName>Griffin</FamilyName>
                  </BibEditorName>
                  <BibEditorName>
                    <Initials>WL</Initials>
                    <FamilyName>Duax</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <Year>1982</Year>
                  <BookTitle>Molecular Structure and Biological Activity</BookTitle>
                  <PublisherName>Elsevier Biomedical</PublisherName>
                  <PublisherLocation>New York, NY</PublisherLocation>
                </BibBook>
                <BibUnstructured>Griffin JF, Duax WL, eds.<Emphasis Type="Italic">Molecular Structure and Biological Activity</Emphasis>. New York, NY: Elsevier Biomedical; 1982.</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Hughes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TW</Initials>
                    <FamilyName>Smith</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HW</Initials>
                    <FamilyName>Kosterlitz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LA</Initials>
                    <FamilyName>Fothergill</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BA</Initials>
                    <FamilyName>Morgan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HR</Initials>
                    <FamilyName>Morris</FamilyName>
                  </BibAuthorName>
                  <Year>1975</Year>
                  <ArticleTitle Language="En">Identification of 2 related pentapeptides from brain with potent opiate agonist activity</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>258</VolumeID>
                  <FirstPage>577</FirstPage>
                  <LastPage>579</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1207728</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/258577a0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaE28XhtVWjurw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hughes J, Smith TW, Kosterlitz HW, Fothergill LA, Morgan BA, Morris HR. Identification of 2 related pentapeptides from brain with potent opiate agonist activity.<Emphasis Type="Italic">Nature</Emphasis>. 1975;258:577–579.</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Temussi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Picone</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MA</Initials>
                    <FamilyName>Castiglione-Morelli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Motta</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Tancredi</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">Bioactive conformation of linear peptides in solution: an elusive goal</ArticleTitle>
                  <JournalTitle>Biopolymers</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <FirstPage>91</FirstPage>
                  <LastPage>107</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2541825</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/bip.360280112</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1MXhsVOqtrY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Temussi PA, Picone D, Castiglione-Morelli MA, Motta A, Tancredi T. Bioactive conformation of linear peptides in solution: an elusive goal.<Emphasis Type="Italic">Biopolymers</Emphasis>. 1989;28:91–107.</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>IL</Initials>
                    <FamilyName>Karle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Karle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Mastropaolo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Camerman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Camerman</FamilyName>
                  </BibAuthorName>
                  <Year>1983</Year>
                  <ArticleTitle Language="En">[Leu-5]enkepalin-4 co-crystallizing conformers with extended backbones that form an anti-parallel beta-sheet</ArticleTitle>
                  <JournalTitle>Acta Crystallogr</JournalTitle>
                  <VolumeID>B39</VolumeID>
                  <FirstPage>625</FirstPage>
                  <LastPage>637</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL3sXls1Ogt7g%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Karle IL, Karle J, Mastropaolo D, Camerman A, Camerman N. [Leu-5]enkepalin-4 co-crystallizing conformers with extended backbones that form an anti-parallel beta-sheet.<Emphasis Type="Italic">Acta Crystallogr</Emphasis>. 1983;B39:625–637.</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Smith</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JF</Initials>
                    <FamilyName>Griffin</FamilyName>
                  </BibAuthorName>
                  <Year>1978</Year>
                  <ArticleTitle Language="En">Conformation of [Leu-5]enkephalin rrom X-ray-diffraction: features important for recognition at opiate receptor</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <VolumeID>199</VolumeID>
                  <FirstPage>1214</FirstPage>
                  <LastPage>1216</LastPage>
                  <Occurrence Type="PID">
                    <Handle>204006</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.204006</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaE1cXhsVOksLc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Smith D, Griffin JF. Conformation of [Leu-5]enkephalin rrom X-ray-diffraction: features important for recognition at opiate receptor.<Emphasis Type="Italic">Science</Emphasis>. 1978;199:1214–1216.</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Aubry</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Birlirakis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Sakarellos-Daitsiotis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Sakarellos</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Marraud</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">A crystal molecular-conformation of leucine-enkephalin related to the morphine molecule</ArticleTitle>
                  <JournalTitle>Biopolymers</JournalTitle>
                  <VolumeID>28</VolumeID>
                  <FirstPage>27</FirstPage>
                  <LastPage>40</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2720108</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/bip.360280106</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1MXhsVyjsbs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Aubry A, Birlirakis N, Sakarellos-Daitsiotis M, Sakarellos C, Marraud M. A crystal molecular-conformation of leucine-enkephalin related to the morphine molecule.<Emphasis Type="Italic">Biopolymers</Emphasis>. 1989;28:27–40.</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Doi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Tanaka</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Ishida</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1987</Year>
                  <ArticleTitle Language="En">Crystal-structures of [Met<Superscript>5</Superscript>] and [(4-bromo)Phe<Superscript>4</Superscript>,Met<Superscript>5</Superscript>]enkephalins: formation of a dimeric antiparallel beta-structure</ArticleTitle>
                  <JournalTitle>J Biochem (Tokyo)</JournalTitle>
                  <VolumeID>101</VolumeID>
                  <FirstPage>485</FirstPage>
                  <LastPage>490</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL2sXhtlWrtb0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Doi M, Tanaka M, Ishida T, et al. Crystal-structures of [Met<Superscript>5</Superscript>] and [(4-bromo)Phe<Superscript>4</Superscript>,Met<Superscript>5</Superscript>]enkephalins: formation of a dimeric antiparallel beta-structure.<Emphasis Type="Italic">J Biochem (Tokyo)</Emphasis>, 1987;101:485–490.</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>GH</Initials>
                    <FamilyName>Loew</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Molecular modeling of opioid analgesics</ArticleTitle>
                  <JournalTitle>Mod Drug Discovery</JournalTitle>
                  <VolumeID>2</VolumeID>
                  <FirstPage>24</FirstPage>
                  <LastPage>30</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXivFKktg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Loew GH. Molecular modeling of opioid analgesics.<Emphasis Type="Italic">Mod Drug Discovery</Emphasis>. 1999;2:24–30.</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibUnstructured>
                  <Emphasis Type="Italic">SHELXTL [Computer program]. Version 6.10</Emphasis>. Madison, Wisconsin: Bruker AXS Inc. 2000.</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JF</Initials>
                    <FamilyName>Griffin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DA</Initials>
                    <FamilyName>Langs</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GD</Initials>
                    <FamilyName>Smith</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TL</Initials>
                    <FamilyName>Blundell</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>IJ</Initials>
                    <FamilyName>Tickle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Bedarkar</FamilyName>
                  </BibAuthorName>
                  <Year>1986</Year>
                  <ArticleTitle Language="En">The crystal-structures of [Met<Superscript>5</Superscript>] enkephalin and a third form of [Leu<Superscript>5</Superscript>] enkephalin: observations of a novel pleated β-sheet</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>83</VolumeID>
                  <FirstPage>3272</FirstPage>
                  <LastPage>3276</LastPage>
                  <Occurrence Type="PID">
                    <Handle>3458181</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.83.10.3272</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL28XktFylu78%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Griffin JF, Langs DA, Smith GD, Blundell TL, Tickle IJ, Bedarkar S. The crystal-structures of [Met<Superscript>5</Superscript>] enkephalin and a third form of [Leu<Superscript>5</Superscript>] enkephalin: observations of a novel pleated β-sheet.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1986;83:3272–3276.</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Deschamps</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Flippen-Anderson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GA</Initials>
                    <FamilyName>Brine</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JP</Initials>
                    <FamilyName>Hayes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>George</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Boc-tyrosyl-D-alanyl-glycyl-N-methyl-pnenylalanyl-O-methyl-methionine hydrate: a protected analog of metkephamid</ArticleTitle>
                  <JournalTitle>Acta Crystallogr</JournalTitle>
                  <VolumeID>58E</VolumeID>
                  <FirstPage>o13</FirstPage>
                  <LastPage>o15</LastPage>
                </BibArticle>
                <BibUnstructured>Deschamps JR, Flippen-Anderson JL, Brine GA, Hayes JP, George C. Boc-tyrosyl-D-alanyl-glycyl-N-methyl-pnenylalanyl-O-methyl-methionine hydrate: a protected analog of metkephamid.<Emphasis Type="Italic">Acta Crystallogr</Emphasis>. 2002;58E:o13-o15.</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Ishida</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Kenmotsu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Mino</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1984</Year>
                  <ArticleTitle Language="En">X-Ray diffraction studies of enkephalins: crystal-structure of [(4’-bromo)Phe<Superscript>4</Superscript>,Leu<Superscript>5</Superscript>] enkephalin</ArticleTitle>
                  <JournalTitle>Biochem J</JournalTitle>
                  <VolumeID>218</VolumeID>
                  <FirstPage>677</FirstPage>
                  <LastPage>689</LastPage>
                  <Occurrence Type="PID">
                    <Handle>6721829</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL2cXhs1yns7s%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ishida T, Kenmotsu M, Mino Y, et al. X-Ray diffraction studies of enkephalins: crystal-structure of [(4’-bromo)Phe<Superscript>4</Superscript>,Leu<Superscript>5</Superscript>] enkephalin.<Emphasis Type="Italic">Biochem J</Emphasis>. 1984;218:677–689.</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JJ</Initials>
                    <FamilyName>Stezowski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Eckle</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Bajusz</FamilyName>
                  </BibAuthorName>
                  <Year>1985</Year>
                  <ArticleTitle Language="En">Crystal-structure determination for Tyr-d-Nle-Gly-Phe-Nles [Nles=MetCH<Subscript>2</Subscript>CH<Subscript>2</Subscript>CH<Subscript>2</Subscript>CH(NH<Subscript>2</Subscript>)SO<Subscript>3</Subscript>H]: an active synthetic enkephalin analog</ArticleTitle>
                  <JournalTitle>J Chem Soc Chem Comm</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <FirstPage>681</FirstPage>
                  <LastPage>682</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1039/c39850000681</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Stezowski JJ, Eckle E, Bajusz SA. Crystal-structure determination for Tyr-d-Nle-Gly-Phe-Nles [Nles=MetCH<Subscript>2</Subscript>CH<Subscript>2</Subscript>CH<Subscript>2</Subscript>CH(NH<Subscript>2</Subscript>)SO<Subscript>3</Subscript>H]: an active synthetic enkephalin analog.<Emphasis Type="Italic">J Chem Soc Chem Comm</Emphasis>. 1985;11:681–682.</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Deschamps</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>George</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Flippen-Anderson</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">[D-Ala<Superscript>2</Superscript>, D-Leu<Superscript>5</Superscript>]-enkephalin (DADLE)</ArticleTitle>
                  <JournalTitle>Acta Crystallogr</JournalTitle>
                  <VolumeID>52</VolumeID>
                  <FirstPage>1583</FirstPage>
                  <LastPage>1585</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1107/S0108270196000534</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Deschamps JR, George C, Flippen-Anderson JL. [D-Ala<Superscript>2</Superscript>, D-Leu<Superscript>5</Superscript>]-enkephalin (DADLE).<Emphasis Type="Italic">Acta Crystallogr</Emphasis>. 1996;52:1583–1585.</BibUnstructured>
              </Citation>
              <Citation ID="CR15">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Flippen-Anderson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Deschamps</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KB</Initials>
                    <FamilyName>Ward</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>George</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Houghten</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">The crystal structure of deltakephalin: a δ-selective opioid peptide with a novel β-bend-like conformation</ArticleTitle>
                  <JournalTitle>Int J Pept Protein Res</JournalTitle>
                  <VolumeID>44</VolumeID>
                  <FirstPage>97</FirstPage>
                  <LastPage>104</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7982763</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXmt1CmsrY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1399-3011.1994.tb00563.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Flippen-Anderson JL, Deschamps JR, Ward KB, George C, Houghten R. The crystal structure of deltakephalin: a δ-selective opioid peptide with a novel β-bend-like conformation.<Emphasis Type="Italic">Int J Pept Protein Res</Emphasis>. 1994;44:97–104.</BibUnstructured>
              </Citation>
              <Citation ID="CR16">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Fournie-Zaluski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Prange</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Pascard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BP</Initials>
                    <FamilyName>Roques</FamilyName>
                  </BibAuthorName>
                  <Year>1977</Year>
                  <ArticleTitle Language="En">Enkephalin related fragments: conformational studies of the tetrapeptides Tyr-Gly-Gly-Phe and Gly-Gly-Phe-X (X=Leu, Met) by X-ray and<Superscript>1</Superscript>H NMR spectroscopy</ArticleTitle>
                  <JournalTitle>Biochem Biophys Res Commun</JournalTitle>
                  <VolumeID>79</VolumeID>
                  <FirstPage>1199</FirstPage>
                  <LastPage>1206</LastPage>
                  <Occurrence Type="PID">
                    <Handle>603654</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaE1cXhtlahs70%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fournie-Zaluski M, Prange T, Pascard C, Roques BP. Enkephalin related fragments: conformational studies of the tetrapeptides Tyr-Gly-Gly-Phe and Gly-Gly-Phe-X (X=Leu, Met) by X-ray and<Superscript>1</Superscript>H NMR spectroscopy.<Emphasis Type="Italic">Biochem Biophys Res Commun</Emphasis>. 1977;79:1199–1206.</BibUnstructured>
              </Citation>
              <Citation ID="CR17">
                <CitationNumber>17.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Flippen-Anderson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Deschamps</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>George</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VJ</Initials>
                    <FamilyName>Hruby</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Misicka</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AW</Initials>
                    <FamilyName>Lipkowski</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Crystal structure of biphalin—multireceptor opioid peptide</ArticleTitle>
                  <JournalTitle>J Pept Res</JournalTitle>
                  <VolumeID>59</VolumeID>
                  <FirstPage>123</FirstPage>
                  <LastPage>133</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11985706</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1034/j.1399-3011.2002.01967.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XitlWjtrk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Flippen-Anderson JL, Deschamps JR, George C, Hruby VJ, Misicka A, Lipkowski AW. Crystal structure of biphalin—multireceptor opioid peptide.<Emphasis Type="Italic">J Pept Res</Emphasis>. 2002;59:123–133.</BibUnstructured>
              </Citation>
              <Citation ID="CR18">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Flippen-Anderson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>George</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Deschamps</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>PA</Initials>
                    <FamilyName>Reddy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AH</Initials>
                    <FamilyName>Lewin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GA</Initials>
                    <FamilyName>Brine</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">X-ray structures of a potent δ-receptor selective opioid antagonist and a protected form of the δ-receptor antagonist ICI 174,864</ArticleTitle>
                  <JournalTitle>Lett Pept Sci</JournalTitle>
                  <VolumeID>1</VolumeID>
                  <FirstPage>107</FirstPage>
                  <LastPage>115</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/BF00128528</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXjvFSnsbs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Flippen-Anderson JL, George C, Deschamps JR, Reddy PA, Lewin AH, Brine GA. X-ray structures of a potent δ-receptor selective opioid antagonist and a protected form of the δ-receptor antagonist ICI 174,864.<Emphasis Type="Italic">Lett Pept Sci</Emphasis>. 1994;1:107–115.</BibUnstructured>
              </Citation>
              <Citation ID="CR19">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Flippen-Anderson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>VJ</Initials>
                    <FamilyName>Hruby</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Collins</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>George</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Cudney</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">X-ray structure of [D-Pen<Superscript>2</Superscript>, D-Pen<Superscript>5</Superscript>]enkephalin, a highly potent, delta-opioid receptor-selective compound: comparisons with proposed solution conformations</ArticleTitle>
                  <JournalTitle>J Am Chem Soc</JournalTitle>
                  <VolumeID>116</VolumeID>
                  <FirstPage>7523</FirstPage>
                  <LastPage>7531</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/ja00096a008</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXltlCku7o%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Flippen-Anderson JL, Hruby VJ, Collins N, George C, Cudney B. X-ray structure of [D-Pen<Superscript>2</Superscript>, D-Pen<Superscript>5</Superscript>]enkephalin, a highly potent, delta-opioid receptor-selective compound: comparisons with proposed solution conformations.<Emphasis Type="Italic">J Am Chem Soc</Emphasis>. 1994;116:7523–7531.</BibUnstructured>
              </Citation>
              <Citation ID="CR20">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N</Initials>
                    <FamilyName>Collins</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Flippen-Anderson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Haaseth</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Conformational determinants of agonist versus antagonist properties of [D-Pen<Superscript>2</Superscript>, D-Pen<Superscript>5</Superscript>]-enkephalin (DPDPE) analogs at opioid receptors: comparison of x-ray crystallographic structure, solution<Superscript>1</Superscript>H NMR data, and molecular dynamic simulations of [L-Ala<Superscript>3</Superscript>]DPDPE and [D-Ala<Superscript>3</Superscript>]DPDPE</ArticleTitle>
                  <JournalTitle>J Am Chem Soc</JournalTitle>
                  <VolumeID>118</VolumeID>
                  <FirstPage>2143</FirstPage>
                  <LastPage>2152</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/ja9531081</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28XhtVKksbs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Collins N, Flippen-Anderson JL, Haaseth R, et al. Conformational determinants of agonist versus antagonist properties of [D-Pen<Superscript>2</Superscript>, D-Pen<Superscript>5</Superscript>]-enkephalin (DPDPE) analogs at opioid receptors: comparison of x-ray crystallographic structure, solution<Superscript>1</Superscript>H NMR data, and molecular dynamic simulations of [L-Ala<Superscript>3</Superscript>]DPDPE and [D-Ala<Superscript>3</Superscript>]DPDPE.<Emphasis Type="Italic">J Am Chem Soc</Emphasis>. 1996;118:2143–2152.</BibUnstructured>
              </Citation>
              <Citation ID="CR21">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>GV</Initials>
                    <FamilyName>Nikiforovich</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KE</Initials>
                    <FamilyName>Kover</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SA</Initials>
                    <FamilyName>Kolodziej</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Design and comprehensive conformational studies of Tyr<Superscript>1</Superscript>-cyclo(D-Pen<Superscript>2</Superscript>-Gly<Superscript>3</Superscript>-Phe<Superscript>5</Superscript>-l-3-Mpt<Superscript>5</Superscript>) and Tyr(1)-cyclo(Pen<Superscript>2</Superscript>-Gly<Superscript>3</Superscript>-Phe<Superscript>5</Superscript>-d-3-Mpt<Superscript>5</Superscript>): novel conformationally constrained opioid peptides</ArticleTitle>
                  <JournalTitle>J Am Chem Soc</JournalTitle>
                  <VolumeID>118</VolumeID>
                  <FirstPage>959</FirstPage>
                  <LastPage>969</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/ja952964+</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK28Xks12jsw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Nikiforovich GV, Kover KE, Kolodziej SA, et al. Design and comprehensive conformational studies of Tyr<Superscript>1</Superscript>-cyclo(D-Pen<Superscript>2</Superscript>-Gly<Superscript>3</Superscript>-Phe<Superscript>5</Superscript>-l-3-Mpt<Superscript>5</Superscript>) and Tyr(1)-cyclo(Pen<Superscript>2</Superscript>-Gly<Superscript>3</Superscript>-Phe<Superscript>5</Superscript>-d-3-Mpt<Superscript>5</Superscript>): novel conformationally constrained opioid peptides.<Emphasis Type="Italic">J Am Chem Soc</Emphasis>. 1996;118:959–969.</BibUnstructured>
              </Citation>
              <Citation ID="CR22">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AL</Initials>
                    <FamilyName>Lomize</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Flippen-Anderson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>George</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>HI</Initials>
                    <FamilyName>Mosberg</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Conformational-analysis of the delta-receptor-selective, cyclic opioid peptide, Tyr-cyclo[D-Cys-Phe-D-Pen]OH (JOM-13): comparison of X-ray crystallographic structures, molecular mechanics simulation, and<Superscript>1</Superscript>H-NMR data</ArticleTitle>
                  <JournalTitle>J Am Chem Soc</JournalTitle>
                  <VolumeID>116</VolumeID>
                  <FirstPage>429</FirstPage>
                  <LastPage>436</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/ja00081a001</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXhtlGisLw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lomize AL, Flippen-Anderson JL, George C, Mosberg HI. Conformational-analysis of the delta-receptor-selective, cyclic opioid peptide, Tyr-cyclo[D-Cys-Phe-D-Pen]OH (JOM-13): comparison of X-ray crystallographic structures, molecular mechanics simulation, and<Superscript>1</Superscript>H-NMR data.<Emphasis Type="Italic">J Am Chem Soc</Emphasis>. 1994;116:429–436.</BibUnstructured>
              </Citation>
              <Citation ID="CR23">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Flippen-Anderson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Deschamps</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>George</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">X-ray structure of Tyr-D-Tic-Phe-Phe-NH<Subscript>2</Subscript> (D-TIPP-NH<Subscript>2</Subscript>), a highly potent μ-receptor selective opioid agonist: comparisons with proposed model structures</ArticleTitle>
                  <JournalTitle>J Pept Res</JournalTitle>
                  <VolumeID>49</VolumeID>
                  <FirstPage>384</FirstPage>
                  <LastPage>393</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9211219</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXjvVWnt70%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1399-3011.1997.tb00890.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Flippen-Anderson JL, Deschamps JR, George C, et al. X-ray structure of Tyr-D-Tic-Phe-Phe-NH<Subscript>2</Subscript> (D-TIPP-NH<Subscript>2</Subscript>), a highly potent μ-receptor selective opioid agonist: comparisons with proposed model structures.<Emphasis Type="Italic">J Pept Res</Emphasis>. 1997;49:384–393.</BibUnstructured>
              </Citation>
              <Citation ID="CR24">
                <CitationNumber>24.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>MR</Initials>
                    <FamilyName>Ciajolo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Balboni</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Picone</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">A solution and solid-state structure of the diketopiperazine of tyrosyl-tetrahydroisoquinoline-3-carboxylic acid</ArticleTitle>
                  <JournalTitle>Int J Pept Protein Res</JournalTitle>
                  <VolumeID>46</VolumeID>
                  <FirstPage>134</FirstPage>
                  <LastPage>138</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8567167</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXotVGhtL0%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1111/j.1399-3011.1995.tb01328.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Ciajolo MR, Balboni G, Picone D, et al. A solution and solid-state structure of the diketopiperazine of tyrosyl-tetrahydroisoquinoline-3-carboxylic acid.<Emphasis Type="Italic">Int J Pept Protein Res</Emphasis>. 1995;46:134–138.</BibUnstructured>
              </Citation>
              <Citation ID="CR25">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Deschamps</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Flippen-Anderson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>George</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">2-[N-(<Emphasis Type="Italic">t</Emphasis>-Butoxy carbonyl)tyrosyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid nitromethane solvate</ArticleTitle>
                  <JournalTitle>Acta Crystallogr</JournalTitle>
                  <VolumeID>57E</VolumeID>
                  <FirstPage>o87</FirstPage>
                  <LastPage>o90</LastPage>
                </BibArticle>
                <BibUnstructured>Deschamps JR, Flippen-Anderson JL, George C. 2-[N-(<Emphasis Type="Italic">t</Emphasis>-Butoxy carbonyl)tyrosyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid nitromethane solvate.<Emphasis Type="Italic">Acta Crystallogr</Emphasis>. 2001;57E:o87-o90.</BibUnstructured>
              </Citation>
              <Citation ID="CR26">
                <CitationNumber>26.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Deschamps</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Flippen-Anderson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Moore</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Cudney</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>George</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Tyrosyl-D-tetrahydroisoquinoline-3-carboxylic acid and tyrosyl-D-tetrahydroisoquinoline-3-carboxamide</ArticleTitle>
                  <JournalTitle>Acta Crystallogr</JournalTitle>
                  <VolumeID>C53</VolumeID>
                  <FirstPage>1478</FirstPage>
                  <LastPage>1482</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXntFaqtLc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Deschamps JR, Flippen-Anderson JL, Moore C, Cudney R, George C. Tyrosyl-D-tetrahydroisoquinoline-3-carboxylic acid and tyrosyl-D-tetrahydroisoquinoline-3-carboxamide.<Emphasis Type="Italic">Acta Crystallogr</Emphasis>. 1997;C53:1478–1482.</BibUnstructured>
              </Citation>
              <Citation ID="CR27">
                <CitationNumber>27.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SD</Initials>
                    <FamilyName>Bryant</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>George</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Flippen-Anderson</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Crystal structures of dipeptides containing the DMT-TIC pharmacophore</ArticleTitle>
                  <JournalTitle>J Med Chem</JournalTitle>
                  <VolumeID>45</VolumeID>
                  <FirstPage>5506</FirstPage>
                  <LastPage>5513</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12459018</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm020330p</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XotlGjsr0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bryant SD, George C, Flippen-Anderson JL, et al. Crystal structures of dipeptides containing the DMT-TIC pharmacophore.<Emphasis Type="Italic">J Med Chem</Emphasis>. 2002;45:5506–5513.</BibUnstructured>
              </Citation>
              <Citation ID="CR28">
                <CitationNumber>28.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>GA</Initials>
                    <FamilyName>Petsko</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">On the other hand…</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <VolumeID>256</VolumeID>
                  <FirstPage>1403</FirstPage>
                  <LastPage>1404</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1604313</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.1604313</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK383psVyltw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Petsko GA. On the other hand….<Emphasis Type="Italic">Science</Emphasis>. 1992;256:1403–1404.</BibUnstructured>
              </Citation>
              <Citation ID="CR29">
                <CitationNumber>29.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RC</Initials>
                    <FamilyName>Milton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SCF</Initials>
                    <FamilyName>Milton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BBH</Initials>
                    <FamilyName>Kent</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Total chemical synthesis of a D-enzyme: the enantiomers of HIV-1 protease show demonstration of reciprocal chiral substrate specificity</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <VolumeID>256</VolumeID>
                  <FirstPage>1445</FirstPage>
                  <LastPage>1448</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1604320</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.1604320</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK38XltFajtbs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Milton RC, Milton SCF, Kent BBH. Total chemical synthesis of a D-enzyme: the enantiomers of HIV-1 protease show demonstration of reciprocal chiral substrate specificity.<Emphasis Type="Italic">Science</Emphasis>. 1992;256:1445–1448.</BibUnstructured>
              </Citation>
              <Citation ID="CR30">
                <CitationNumber>30.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Coster</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KS</Initials>
                    <FamilyName>Knol</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JA</Initials>
                    <FamilyName>Prins</FamilyName>
                  </BibAuthorName>
                  <Year>1930</Year>
                  <ArticleTitle Language="De">Unterschiede in der intensität der röntgenstrahlen-feflexion an den beiden 111-flächen der zinkblende</ArticleTitle>
                  <JournalTitle>Z Phys</JournalTitle>
                  <VolumeID>63</VolumeID>
                  <FirstPage>345</FirstPage>
                  <LastPage>369</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/BF01339610</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaA3cXlt1SltA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Coster D, Knol KS, Prins JA. Unterschiede in der intensität der röntgenstrahlen-feflexion an den beiden 111-flächen der zinkblende.<Emphasis Type="Italic">Z Phys</Emphasis>. 1930;63:345–369.</BibUnstructured>
              </Citation>
              <Citation ID="CR31">
                <CitationNumber>31.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Bijvoet</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AF</Initials>
                    <FamilyName>Peerdeman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AJ</Initials>
                    <FamilyName>Bommel</FamilyName>
                    <Particle>van</Particle>
                  </BibAuthorName>
                  <Year>1951</Year>
                  <ArticleTitle Language="En">Determination of the absolute configuration of optically active compounds by means of X-rays</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>168</VolumeID>
                  <FirstPage>271</FirstPage>
                  <LastPage>272</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/168271a0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaG38Xnslam</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bijvoet JM, Peerdeman AF, van Bommel AJ. Determination of the absolute configuration of optically active compounds by means of X-rays.<Emphasis Type="Italic">Nature</Emphasis>. 1951;168:271–272.</BibUnstructured>
              </Citation>
              <Citation ID="CR32">
                <CitationNumber>32.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>HD</Initials>
                    <FamilyName>Flack</FamilyName>
                  </BibAuthorName>
                  <Year>1983</Year>
                  <ArticleTitle Language="En">On enantiomorph-polarity estimation</ArticleTitle>
                  <JournalTitle>Acta Crystallogr</JournalTitle>
                  <VolumeID>A39</VolumeID>
                  <FirstPage>876</FirstPage>
                  <LastPage>881</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL3sXmtVeqtLo%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Flack HD. On enantiomorph-polarity estimation.<Emphasis Type="Italic">Acta Crystallogr</Emphasis>. 1983;A39:876–881.</BibUnstructured>
              </Citation>
              <Citation ID="CR33">
                <CitationNumber>33.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PW</Initials>
                    <FamilyName>Schiller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TMD</Initials>
                    <FamilyName>Nguyen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Weltrowska</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Differential stereochemical requirments of μ vs δ opioid receptors for ligand binding and signal transduction: development of a class of potent and highly δ-selective peptide antagonists</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>89</VolumeID>
                  <FirstPage>11871</FirstPage>
                  <LastPage>11875</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1334552</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.89.24.11871</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXisVOrsLg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Schiller PW, Nguyen TMD, Weltrowska G, et al. Differential stereochemical requirments of μ vs δ opioid receptors for ligand binding and signal transduction: development of a class of potent and highly δ-selective peptide antagonists.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1992;89:11871–11875.</BibUnstructured>
              </Citation>
              <Citation ID="CR34">
                <CitationNumber>34.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Balboni</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Guerrini</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Salvadori</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Evaluation of the Dmt-Tic pharmacophore: conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties</ArticleTitle>
                  <JournalTitle>J Med Chem</JournalTitle>
                  <VolumeID>45</VolumeID>
                  <FirstPage>713</FirstPage>
                  <LastPage>720</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11806723</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm010449i</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XhsVajuw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Balboni G, Guerrini R, Salvadori S, et al. Evaluation of the Dmt-Tic pharmacophore: conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties.<Emphasis Type="Italic">J Med Chem</Emphasis>. 2002;45:713–720.</BibUnstructured>
              </Citation>
              <Citation ID="CR35">
                <CitationNumber>35.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>NB</Initials>
                    <FamilyName>Eddy</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>EL</Initials>
                    <FamilyName>May</FamilyName>
                  </BibAuthorName>
                  <Year>1973</Year>
                  <ArticleTitle Language="En">The search for a better analgesic</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <VolumeID>181</VolumeID>
                  <FirstPage>407</FirstPage>
                  <LastPage>414</LastPage>
                  <Occurrence Type="PID">
                    <Handle>4123997</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.181.4098.407</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaE3sXkvFWjtrw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Eddy NB, May EL. The search for a better analgesic.<Emphasis Type="Italic">Science</Emphasis>. 1973;181:407–414.</BibUnstructured>
              </Citation>
              <Citation ID="CR36">
                <CitationNumber>36.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>PW</Initials>
                    <FamilyName>Schiller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CF</Initials>
                    <FamilyName>Yam</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Lis</FamilyName>
                  </BibAuthorName>
                  <Year>1977</Year>
                  <ArticleTitle Language="En">Evidence of topographical analogy between methionine-enkephalin and morphine derivatives</ArticleTitle>
                  <JournalTitle>Biochemistry</JournalTitle>
                  <VolumeID>16</VolumeID>
                  <FirstPage>1831</FirstPage>
                  <LastPage>1838</LastPage>
                  <Occurrence Type="PID">
                    <Handle>870028</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/bi00628a011</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaE2sXktlentr8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Schiller PW, Yam CF, Lis M. Evidence of topographical analogy between methionine-enkephalin and morphine derivatives.<Emphasis Type="Italic">Biochemistry</Emphasis>. 1977;16:1831–1838.</BibUnstructured>
              </Citation>
              <Citation ID="CR37">
                <CitationNumber>37.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Gylbert</FamilyName>
                  </BibAuthorName>
                  <Year>1973</Year>
                  <ArticleTitle Language="En">The crystal and molecule structure of morphine hydrochloride trihydrate</ArticleTitle>
                  <JournalTitle>Acta Crystallogr</JournalTitle>
                  <VolumeID>B29</VolumeID>
                  <FirstPage>1630</FirstPage>
                  <LastPage>1635</LastPage>
                </BibArticle>
                <BibUnstructured>Gylbert L. The crystal and molecule structure of morphine hydrochloride trihydrate.<Emphasis Type="Italic">Acta Crystallogr</Emphasis>. 1973;B29:1630–1635.</BibUnstructured>
              </Citation>
              <Citation ID="CR38">
                <CitationNumber>38.</CitationNumber>
                <BibBook>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Thomas</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <BookTitle>Medicinal Chemistry: An Introduction</BookTitle>
                  <PublisherName>John Wiley &amp; Sons</PublisherName>
                  <PublisherLocation>Chichester, UK</PublisherLocation>
                </BibBook>
                <BibUnstructured>Thomas G.<Emphasis Type="Italic">Medicinal Chemistry: An Introduction</Emphasis>. Chichester, UK: John Wiley &amp; Sons; 2000.</BibUnstructured>
              </Citation>
              <Citation ID="CR39">
                <CitationNumber>39.</CitationNumber>
                <BibBook>
                  <BibAuthorName>
                    <Initials>WO</Initials>
                    <FamilyName>Foye</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>TL</Initials>
                    <FamilyName>Lemke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DA</Initials>
                    <FamilyName>Williams</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <BookTitle>Principles of Medicinal Chemistry</BookTitle>
                  <PublisherName>Williams &amp; Wilkins</PublisherName>
                  <PublisherLocation>Baltimore, MD</PublisherLocation>
                </BibBook>
                <BibUnstructured>Foye WO, Lemke TL, Williams DA.<Emphasis Type="Italic">Principles of Medicinal Chemistry</Emphasis>. Baltimore, MD: Williams &amp; Wilkins; 1995.</BibUnstructured>
              </Citation>
              <Citation ID="CR40">
                <CitationNumber>40.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AG</Initials>
                    <FamilyName>Michel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Evrard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B</Initials>
                    <FamilyName>Norberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Milchert</FamilyName>
                  </BibAuthorName>
                  <Year>1988</Year>
                  <ArticleTitle Language="En">Molecular-Structure of Opiate Alkaloids. 2. Crystal-Structures of 4-Methylhomobenzomorphan Hydrobromide (I) and 4,12-beta-Dimethylhomobenzomorphan (II)</ArticleTitle>
                  <JournalTitle>Can J Chem</JournalTitle>
                  <VolumeID>66</VolumeID>
                  <FirstPage>1763</FirstPage>
                  <LastPage>1769</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1139/v88-284</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1MXjvFaiuw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Michel AG, Evrard G, Norberg B, Milchert E. Molecular-Structure of Opiate Alkaloids. 2. Crystal-Structures of 4-Methylhomobenzomorphan Hydrobromide (I) and 4,12-beta-Dimethylhomobenzomorphan (II).<Emphasis Type="Italic">Can J Chem</Emphasis>. 1988;66:1763–1769.</BibUnstructured>
              </Citation>
              <Citation ID="CR41">
                <CitationNumber>41.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JB</Initials>
                    <FamilyName>Thomas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>XL</Initials>
                    <FamilyName>Zheng</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>SW</Initials>
                    <FamilyName>Mascarella</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">N-substituted 9β-methyl-5-(3-hyroxyphenyl)morphans are opioid receptor pure antagonists</ArticleTitle>
                  <JournalTitle>J Med Chem</JournalTitle>
                  <VolumeID>41</VolumeID>
                  <FirstPage>4143</FirstPage>
                  <LastPage>4149</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9767649</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm980290i</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXmtVSlu7g%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Thomas JB, Zheng XL, Mascarella SW, et al. N-substituted 9β-methyl-5-(3-hyroxyphenyl)morphans are opioid receptor pure antagonists.<Emphasis Type="Italic">J Med Chem</Emphasis>. 1998;41:4143–4149.</BibUnstructured>
              </Citation>
              <Citation ID="CR42">
                <CitationNumber>42.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Hashimoto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AE</Initials>
                    <FamilyName>Jabobson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RB</Initials>
                    <FamilyName>Rothman</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Probes for narcotic receptor mediated phenomena. 28. New opioid antagonists from enantiomeric analogues of<Emphasis Type="Italic">m</Emphasis>-hydroxyphenyl-N-phenylethylmorphan</ArticleTitle>
                  <JournalTitle>Bioorg Med Chem</JournalTitle>
                  <VolumeID>10</VolumeID>
                  <FirstPage>3319</FirstPage>
                  <LastPage>3329</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12150879</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0968-0896(02)00219-5</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XlvVemsLc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hashimoto A, Jabobson AE, Rothman RB, et al. Probes for narcotic receptor mediated phenomena. 28. New opioid antagonists from enantiomeric analogues of<Emphasis Type="Italic">m</Emphasis>-hydroxyphenyl-N-phenylethylmorphan.<Emphasis Type="Italic">Bioorg Med Chem</Emphasis>. 2002;10:3319–3329.</BibUnstructured>
              </Citation>
              <Citation ID="CR43">
                <CitationNumber>43.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>JL</Initials>
                    <FamilyName>Flippen-Anderson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>George</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CM</Initials>
                    <FamilyName>Bertha</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KC</Initials>
                    <FamilyName>Rice</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">X-ray crystal structures of potent opioid receptor ligands: etonitazene,<Emphasis Type="Italic">cis</Emphasis>-(+)-3-methylfentanyl, etorphine, diprenorphine, and buprenorphine</ArticleTitle>
                  <JournalTitle>Heterocycles</JournalTitle>
                  <VolumeID>39</VolumeID>
                  <FirstPage>751</FirstPage>
                  <LastPage>766</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXjtlaiurY%3D</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.3987/COM-94-S(B)70</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Flippen-Anderson JL, George C, Bertha CM, Rice KC. X-ray crystal structures of potent opioid receptor ligands: etonitazene,<Emphasis Type="Italic">cis</Emphasis>-(+)-3-methylfentanyl, etorphine, diprenorphine, and buprenorphine.<Emphasis Type="Italic">Heterocycles</Emphasis>. 1994;39:751–766.</BibUnstructured>
              </Citation>
              <Citation ID="CR44">
                <CitationNumber>44.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>VJ</Initials>
                    <FamilyName>Hruby</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>CA</Initials>
                    <FamilyName>Gehrig</FamilyName>
                  </BibAuthorName>
                  <Year>1989</Year>
                  <ArticleTitle Language="En">Recent developments in the design of receptor specifico-peptides</ArticleTitle>
                  <JournalTitle>Med Res Rev</JournalTitle>
                  <VolumeID>9</VolumeID>
                  <FirstPage>343</FirstPage>
                  <LastPage>401</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2547125</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/med.2610090306</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1MXkslSiurc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hruby VJ, Gehrig CA. Recent developments in the design of receptor specifico-peptides.<Emphasis Type="Italic">Med Res Rev</Emphasis>. 1989;9:343–401.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
